glp-1 shortage news today november 2025 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Trends by CivicScience: Weight-Loss

Heres the balanced answer: Licensed pharmacies prepare compounded medications They are not FDA-approved in the same way as branded drugs Quality can depend on the pharmacy and preparation standards This does not automatically make them unsafe, but it does mean they are different from FDA-approved products like Wegovy or Ozempic

Furthermore, patients treated with the dual GLP-1R and GIP agonist tirzepatide exhibited lower Food Craving Inventory scores for sweets and high-fat fast foods compared to those receiving liraglutide, indicating a greater reduction in desire for these items during weight loss (Martin et al., 2025)

Glutathione, oxidative stress and neurodegeneration

The risk: similar to PPIs, they lower stomach acid and reduce absorption, though the effect is typically milder

most importantly, higher AMPK activity was maintained after chronic ethanol exposure

You are not doubling down on one pathway